" Evaluation of Erythropoietin Therapy in Patients With End-Stage Kidney Disease on Regular Hemodialysis: Hemoglobin Outcomes, and Metabolic Syndrome as a Risk Factor for Erythropoietin Resistance "

NCT06983756 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Erythropoietin Resistant Anemia (EPO Resistant Anemia)

Interventions

DRUG: Erythropoietin

Sponsor

Fayoum University